Journal of South Asian Federation of Obstetrics and Gynaecology

Register      Login

VOLUME 13 , ISSUE 3 ( May-June, 2021 ) > List of Articles

Original Article

Study on Outcomes of Pregnancy in Women with Placenta Accreta Spectrum: A 10-year Study in a Tertiary Care Center

Bhuvana Srinivasan, Naveena Balasubramanian, Jaya Vijayaraghavan, Santosh Joseph, Usha Rani, Usha Vishwanath, Narayanan Palaniappan, Rajeswari Krishnan Subrahmanyam, Dhanalakshmi Marianallur Ganesan, Vasantha Lakshmi

Keywords : Accreta, Increta, Obstetric hemorrhage, Obstetric hysterectomy, Percreta, Uterine artery embolization

Citation Information : Srinivasan B, Balasubramanian N, Vijayaraghavan J, Joseph S, Rani U, Vishwanath U, Palaniappan N, Subrahmanyam RK, Ganesan DM, Lakshmi V. Study on Outcomes of Pregnancy in Women with Placenta Accreta Spectrum: A 10-year Study in a Tertiary Care Center. J South Asian Feder Obs Gynae 2021; 13 (3):94-97.

DOI: 10.5005/jp-journals-10006-1903

License: CC BY-NC 4.0

Published Online: 09-09-2021

Copyright Statement:  Copyright © 2021; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Introduction: Placenta accreta spectrum (PAS) disorders include accreta, increta, and percreta, which are associated with increased maternal morbidity and mortality. Obstetric hysterectomy for PAS disorders is more associated with massive obstetric hemorrhage than the conservative management methods. Aim: To study the outcomes in women with PAS in a tertiary care center—uterine preservation (conservative) versus obstetric hysterectomy with arterial embolization. Materials and methods: The patients were divided into three groups: group I included women in whom placenta left in situ with uterine artery embolization (UAE) done, group II included women with partial accreta undergone placenta removal followed by UAE, and group III included women who underwent obstetric hysterectomy with arterial embolization. Results: A total of 43 women were included in this study between 2010 and 2020. Among 43 women, 28 (65.11%) had accreta, 10 (23.25%) had increta, and 5 (11.62%) had percreta. Group I had 24 (55.81%) women managed by leaving the placenta in situ with UAE done. Group II had 9 (20.93%) women undergone placental removal in toto followed by UAE, and group III had 10 (23.25%) women who underwent obstetric hysterectomy with arterial embolization. The outcomes were studied among the three groups in terms of the amount of intrapartum blood loss, ICU admissions, prolonged hospital stay, bladder injury, and disseminated intravascular coagulation. The blood loss and postoperative complications were more in group III, which was statistically significant (p < 0.0001). There was no maternal mortality in our study. Conclusion: Conservative management by leaving the placenta in situ with arterial embolization helps women to retain the uterus and reduces maternal morbidity in PAS disorders.


PDF Share
  1. Cahill AG, Beigi R, Heine RP, et al. Placenta accreta spectrum. Am J Obstet Gynecol 2018;219(6):B2–B16. DOI: 10.1016/j.ajog.2018.09.042.
  2. Trikha A, Singh PM. Management of major obstetric haemorrhage. Indian J Anaesth 2018;62(9):698. DOI: 10.4103/ija.IJA_448_18.
  3. Silver RM, Branch DW. Placenta accreta spectrum. N Engl J Med 2018;378(16):1529–1536. DOI: 10.1056/NEJMcp1709324.
  4. Huang KL, Tsang LL, Cheng YF, et al. Planned conservative management of placenta increta and percreta with prophylactic transcatheter arterial embolization and leaving placenta in situ for women who desire fertility preservation. Placenta 2020;97:51–57. DOI: 10.1016/j.placenta.2020.06.003.
  5. Carusi DA. The placenta accreta spectrum: epidemiology and risk factors. Clin Obstet Gynecol 2018;61(4):733–742. DOI: 10.1097/GRF.0000000000000391.
  6. Listijono DR, Chuah SC, Rahimpanah F. Management of placenta accreta in an Australian tertiary referral centre: a ten-year experience. Clin Exp Obstet Gynecol 2017;44(3):374–378. DOI: 10.12891/ceog3516.2017.
  7. Sentilhes L, Deneux-Tharaux C, Seco A, et al. Conservative management versus cesarean hysterectomy for placenta accreta spectrum; the PACCRETA prospective population-based study. Am J Obstet Gynecol 2020;222(1):S3–S4. DOI: 10.1016/j.ajog.2019.11.020.
  8. Jauniaux ER, Alfirevic Z, Bhide AG, et al. Placenta praevia and placenta accreta: diagnosis and management. Green-top Guideline No. 27a. BJOG 2018;126(1):e1. DOI: 10.1111/1471-0528.15306.
  9. Wang J, Shi X, Li Y, et al. Prophylactic intraoperative uterine or internal iliac artery embolization in planned cesarean for pernicious placenta previa in the third trimester of pregnancy: an observational study (STROBE compliant). Medicine 2019;98(44):e17767. DOI: 10.1097/MD.0000000000017767.
  10. Miyakoshi K, Otani T, Kondoh E, et al. Perinatal Research Network Group in Japan. Retrospective multicenter study of leaving the placenta in situ for patients with placenta previa on a cesarean scar. Int J Gynecol Obstet 2018;140(3):345–351. DOI: 10.1002/ijgo.12397.
  11. Sentilhes L, Kayem G, Chandraharan E, et al. FIGO consensus guidelines on placenta accreta spectrum disorders: conservative management. Int J Gynecol Obstet 2018;140(3):291–298. DOI: 10.1002/ijgo.12410.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.